🇺🇸 Spiolto® Respimat® in United States

Spiolto® Respimat® (Spiolto® Respimat®) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Spiolto® Respimat® in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Spiolto® Respimat® approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Spiolto® Respimat® in United States?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.